Analystreport

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its price target lowered by analysts at BMO Capital Markets from $45.00 to $38.00.

Phathom Pharmaceuticals, Inc.  (PHAT) 
Last phathom pharmaceuticals, inc. earnings: 3/19 08:31 am Check Earnings Report